胎盘功能不全标志物评估早发型胎儿生长受限非染色体遗传病风险
评估sFlt-1/PlGF比值、PlGF、子宫动脉PI和胎儿多普勒对遗传异常的筛查价值。结果显示sFlt-1/PlGF比值<38或PlGF≥100 pg/mL时遗传异常检出率显著较高,提示胎盘功能不全标志物可优化WES使用和产前咨询。
要点
- 孤立性早发型FGR中总体遗传异常检出率为2.9%。
- sFlt-1/PlGF比值≥38或PlGF<45 pg/mL的病例中未发现遗传异常。
- 联合胎盘功能不全标志物可识别遗传异常风险更高或更低的亚组。
核心结论
- 胎盘功能不全标志物,尤其是sFlt-1/PlGF比值和PlGF水平,可对孤立性早发型FGR的遗传异常风险进行精细化分层。
- 联合子宫动脉PI和胎儿多普勒等标志物可能识别遗传异常风险更高的小亚组,提高WES诊断效能。
研究设计与样本
- 纳入238例孕20+0至28+6周诊断的孤立性早发型FGR单胎妊娠,估测胎儿体重≤第3百分位。
- 遗传异常通过产前或产后染色体微阵列分析(CMA)或全外显子测序(WES)确认。
主要发现
- 238例孤立性早发型FGR中检出7例遗传异常,总体检出率为2.9%。
- 7例遗传异常中2例(28.6%)由产前或产后CMA检出,5例(71.4%)由产后WES检出。
- sFlt-1/PlGF比值<38亚组遗传异常检出率显著高于总体队列。
- PlGF≥100 pg/mL亚组遗传异常检出率显著高于总体队列。
- sFlt-1/PlGF比值≥38或PlGF<45 pg/mL的病例中未发现遗传异常。
关键数值与推荐
- 孤立性早发型FGR定义为孕20+0至28+6周估测胎儿体重≤第3百分位。
- 按sFlt-1/PlGF比值以38为界值分层:<38与≥38。
- 按PlGF水平以100 pg/mL为界值分层:<100与≥100 pg/mL;另观察PlGF<45 pg/mL。
- 子宫动脉平均PI以第95百分位为界值分层。
- 胎儿多普勒异常定义为脐动脉或静脉导管PI>第95百分位,或大脑中动脉PI或脑胎盘比<第5百分位。
临床怎么用
- 对孤立性早发型FGR病例检测sFlt-1/PlGF比值和PlGF水平有助于遗传咨询和WES使用决策。
- sFlt-1/PlGF比值≥38或PlGF<45 pg/mL的病例遗传异常可能性低,WES诊断收益可能有限。
- 联合子宫动脉PI与胎儿多普勒等标志物可进一步优化遗传异常风险分层。
局限性
- 遗传异常病例数仅7例,亚组分析可靠性受样本量限制。
- 部分遗传异常仅由产后WES检出,产前诊断效能无法完全评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the value of placental insufficiency markers for estimating the risk of genetic anomalies in fetuses with isolated early-onset fetal growth restriction (FGR), defined as an estimated fetal weight ≤ 3rd percentile diagnosed ≤ 28 + 6 weeks' gestation. METHODS: We performed a retrospective analysis of data collected prospectively from cases that attended Vall d'Hebron University Hospital, Barcelona, Spain, between February 2016 and December 2022. Singleton pregnancies diagnosed with isolated early-onset FGR between 20 + 0 and 28 + 6 weeks' gestation were eligible for inclusion. Cases in which a pathogenic or likely pathogenic fetal genetic abnormality was detected by chromosomal microarray (CMA) or whole-exome sequencing (WES) were identified. Cases were stratified by soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio (< 38 vs ≥ 38), PlGF level (< 100 vs ≥ 100 pg/mL), mean uterine artery (UtA) pulsatility index (PI) (< 95th vs ≥ 95th percentile) and fetal Doppler (normal vs abnormal) at the time of FGR diagnosis. Abnormal fetal Doppler was defined as a PI > 95th percentile in the umbilical artery or ductus venosus, or a middle cerebral artery PI or cerebroplacental ratio < 5th percentile. The prevalence of genetic anomalies in each subgroup was compared with that of the overall cohort. Additionally, combinations of markers of placental insufficiency were investigated to determine whether specific combinations could improve the ability to identify cases at risk of genetic anomaly. RESULTS: In the total cohort of 238 cases of isolated early-onset FGR, seven (2.9%) cases of genetic anomaly were detected. Of these, 2/7 (28.6%) were detected by prenatal or postnatal CMA and 5/7 (71.4%) by postnatal WES. Fetal Doppler alone and UtA-PI alone did not identify subgroups with a significantly different prevalence of genetic abnormality compared with the overall cohort. In contrast, a sFlt-1/PlGF ratio < 38 and PlGF level ≥ 100 pg/mL defined subgroups with a significantly higher prevalence of genetic abnormality, while no genetic anomalies were found in cases with a sFlt-1/PlGF ratio ≥ 38 or PlGF level < 45 pg/mL. Furthermore, smaller subgroups combining markers of placental insufficiency identified cases at significantly higher or lower risk of FGR-related genetic anomaly. CONCLUSIONS: Placental insufficiency markers, particularly the sFlt-1/PlGF ratio and PlGF level, may enable refined risk stratification of genetic anomalies in cases of isolated early-onset FGR, which could be used to provide individualized prenatal counseling and to optimize the use of WES. Furthermore, combining markers of placental insufficiency, such as UtA-PI and fetal Doppler, may improve risk stratification, potentially defining smaller subgroups with a higher prevalence of genetic anomalies, for which WES may provide greater diagnostic yield. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Armengol-Alsina, Bonacina, Dalmau, et al. Placental insufficiency markers to assess the risk of non-chromosomal genetic conditions in early-onset fetal growth restriction. Ultrasound Obstet Gynecol. 2026. PMID: 41906976. doi:10.1002/uog.70211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。